Aquestive Therapeutics (AQST) Revenue (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Revenue of $14.4 million for Q1 2026, up 65.67% year-over-year from $8.7 million in Q1 2025, and up 147.22% quarter-over-quarter from -$30.6 million in Q4 2025.
Aquestive Therapeutics (AQST) Revenue (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Revenue history runs 10 years deep, the most recent figure standing at $14.4 million for Q1 2026.
- In Q1 2026, Revenue rose 65.67% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $6.7 million (down 87.71% YoY), while the FY2025 annual figure was $938000.0, down 98.37% from the prior year.
- Revenue for Q1 2026 stood at $14.4 million, up from -$30.6 million in the prior quarter.
- The five-year high for Revenue was $20.1 million in Q2 2024, with the low at -$30.6 million in Q4 2025.
- The 5-year median for Revenue is $12.1 million (2024), against an average of $9.8 million.
- The sharpest annual moves came in 2022 and 2025: Revenue soared 300.0% in 2022, then sank 357.79% in 2025.
- Aquestive Therapeutics' Revenue stood at $10.7 million in 2022, then grew by 23.63% to $13.2 million in 2023, then declined by 10.14% to $11.9 million in 2024, then plunged by 357.79% to -$30.6 million in 2025, then soared by 147.22% to $14.4 million in 2026.
- Business Quant data shows AQST's Revenue at $14.4 million in Q1 2026, -$30.6 million in Q4 2025, and $12.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Aquestive Therapeutics | 565.72 Mn | 565.72 Mn | 9.80 Mn | 13.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 Mn |
| Mar 31, 2026 | 14.45 Mn |
| Dec 31, 2025 | -30.59 Mn |
| Sep 30, 2025 | 12.81 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 8.72 Mn |
| Dec 31, 2024 | 11.87 Mn |
| Sep 30, 2024 | 13.54 Mn |
| Jun 30, 2024 | 20.10 Mn |
| Mar 31, 2024 | 12.05 Mn |
| Dec 31, 2023 | 13.21 Mn |
| Sep 30, 2023 | 13.00 Mn |
| Jun 30, 2023 | 13.24 Mn |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | 10.68 Mn |
| Sep 30, 2022 | 11.46 Mn |
| Jun 30, 2022 | 8.00 Mn |
| Mar 31, 2022 | 12.27 Mn |
| Dec 31, 2021 | 11.08 Mn |
| Sep 30, 2021 | 13.29 Mn |